1.24.20
4 min. read

M&A multiples. Verily FDA. Hires: Otsuka, Astellas, Sanofi, Sandoz.

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Issue 036. Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 58 percent open rate. Here's what's happening this week:

  • Thanks for all the suggestions for the Omada Health report. Aiming to post and send that your way next week.
  • Jones Day published a lengthy recap of major 2019 policy changes related to digital health around the world. Well worth a look if you operate globally.
  • STAT has a must-read piece on Akili Interactive's FDA purgatory, which includes this quote from CEO Eddie Martucci: “The process is obviously longer than some of us had hoped, I can say that much. And any disappointment is more that we’re not yet getting a product to ADHD families that they really need.”
  • At a talk in Ireland, Apple CEO Tim Cook hinted at future health products from Apple along the lines of its FDA-cleared ECG app on its Watch:
×

Recent Articles